Posts in category Business Standard
Just Dial climbs as Q4 PAT surges 38% YoY to Rs 116 cr (18-04-2024)
Just Dial surged 9.84% to Rs 982 after the company's net profit jumped 38.02% to Rs 115.65 crore on 16.23% rise in revenue from operations to Rs 270.27 crore in Q4 FY24 over Q4 FY23.
RBI comes up with draft guidelines on payment aggregators (18-04-2024)
Powered by Capital Market - Live News
Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant (18-04-2024)
Marksans Pharma slipped 1.50% to Rs 173.85 after the United States Food and Drug Administration (US FDA) issued 5 observations in Form 483 after inspecting the company's Goa-based plant.
Ramkrishna Forgings strengthens its position in e-PV segment (18-04-2024)
Receives approval from USA's larges e-PV manufacturer for supply of power train components
DXY Futures Snap Recent Rally; 105 Mark Stays Intact (18-04-2024)
The dollar index futures slipped back to a week low on Thursday, unable to hold on to the recent streak of gains towards a 6-month high. Currently, the dollar index futures are quoting at 105.68, down 0.09% on the day but staying intact well above the crucial 105 mark. The greenback is losing sheen after a five day rally tracking rising US benchmark treasury yields at around 4.56% amid hawkish bets on Fed action. Federal Reserve Chair Powell was seen hawkish on Tuesday and warned that there is little progress on inflation reducing possibility of a near term rate cut. However, DXY futures failed to hold on to higher levels as global risk appetite seemingly improved. Respite from Middle East tensions also reduced safe haven demand for the global reserve currency. Investors now await comments from FOMC members due later today for further cues on interest rates. Among the basket currencies, EURUSD and GBPUSD recovered slightly to $1.0713 and $1.2481 respectively.
Biocon jumps after inking pact with Biomm SA (18-04-2024)
Biocon gained 2.91% to Rs 270.75 after the company has signed a licensing and supply agreement with Biomm S.A., for the commercialization of Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes.
Marksans Pharma’s Goa unit concludes USFDA inspection with observations (18-04-2024)
On conclusion of the inspection, the Company has received 5 inspectional observations in form 483. There is no data integrity observation. The Company will work closely with the USFDA and is committed to address these observations comprehensively within the stipulated time.
Nifty climbs 22,250; metal stocks shine (18-04-2024)
At 11:30 IST, the barometer index, the S&P BSE Sensex, was up 363.41 points or 0.50% to 73,307.09. The Nifty 50 index added 139.30 points or 0.63% to 22,287.20.
Dynacons Systems zooms 39% on Rs 233-crore order win from Nabard (18-04-2024)
Average trading volumes on the counter jumped over five-fold today with a combined 741,000 equity shares having changed hands on the NSE and BSE so far in trade
Gretex Corporate Services consolidated net profit rises 33.61% in the March 2024 quarter (18-04-2024)
Sales rise 1077.37% to Rs 83.24 crore